Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$13.22 - $19.09 $719,168 - $1.04 Million
-54,400 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$16.68 - $23.97 $112,439 - $161,581
-6,741 Reduced 11.03%
54,400 $1.01 Million
Q4 2020

Feb 02, 2021

SELL
$14.8 - $21.15 $16,280 - $23,265
-1,100 Reduced 1.77%
61,141 $1.08 Million
Q3 2020

Nov 05, 2020

BUY
$15.21 - $25.53 $306,435 - $514,352
20,147 Added 47.86%
62,241 $954,000
Q2 2020

Aug 12, 2020

BUY
$15.08 - $26.0 $483,977 - $834,444
32,094 Added 320.94%
42,094 $1.07 Million
Q4 2019

Jan 27, 2020

BUY
$5.24 - $12.96 $52,400 - $129,600
10,000 New
10,000 $111,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $751M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.